Pricing pressures, high raw material costs could cast damper on Q4 pharma earnings
NEW DELHI: Amid what has so far been a mixed scorecard for India Inc’s fourth quarter earnings, companies in the healthcare space are likely to report weak numbers in the last quarter…
Read More...
Read More...